+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 19Years +
All Genders
ID04968808

Optimal Timing of FFR-Guided Complete Revascularization in Patients With Non-ST-Segment Elevation Myocardial Infarction and Multivessel Disease

Led by Chonnam National University Hospital · Updated on 2026-07-28

1014

Participants Needed

1

Research Sites

208 weeks

Total Duration

AI-Summary

What This Trial Is About

Patients with non-ST-segment elevation myocardial infarction NSTEMI often have multivessel coronary artery disease MVD, which can lead to worse clinical outcomes. Researchers are conducting a prospective, open-label, randomized trial to compare two strategies for revascularization in these patients immediate complete revascularization during the initial procedure and a staged approach where non-infarct arteries are treated several days later. This study addresses the gap in knowledge about the best timing and use of fractional flow reserve FFR in treating non-infarct arteries in NSTEMI with MVD. The trial involves two groups. One group receives immediate complete revascularization where both the infarct-related artery IRA and non-IRA lesions are treated during the initial percutaneous coronary intervention PCI. The other group undergoes staged revascularization, with PCI performed on the IRA first, followed by PCI on non-IRA lesions during the same hospital stay but on a different day. Non-IRA lesions with 70% or greater diameter narrowing are treated without FFR, while those with 50-69% narrowing are evaluated using FFR. Lesions with FFR values above 0.8 are deferred, while those with 0.8 or below are revascularized. Participants will be followed for up to 12 months to assess outcomes including death, non-fatal myocardial infarction, and any unplanned revascularization. The study monitors various secondary outcomes such as kidney function impact, rates of repeat procedures, heart failure hospitalizations, strokes, bleeding events, and stent thrombosis over extended periods. Patients will undergo PCI procedures, and clinical follow-up visits will track safety and effectiveness of the strategies compared.

CONDITIONS

Brief Title

Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI)

Research Team

M

Min Chul Kim, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here